Under the collegial leadership of the four directors Thomas Braun, Stefan Offermanns, Didier Stainier and Werner Seeger. They are jointly responsible for the scientific and administrative management of the institute. The current business is carried out by the managing director appointed from among the directors for a limited period. From July 1, 2020 to June 30, 2023, Prof. Dr. Stefan Offermanns true.

Specialties include Heart and Lung Research, Medicine, Oncology, Genetics, Pharmacology, Pneumology, Cardiovascular Research, and Pulmonary Research